Panitumumab: new drug. Metastatic colorectal cancer: don't make things worse!
Prescrire International 18(102): 157
2009
ISSN/ISBN: 1167-7422 PMID: 19743571 Document Number: 629630
Document emailed within 1 workday
Related Documents
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954Pfeiffer, P.; Jensen, B.V. 2005: Drug therapy of patients with metastatic colorectal cancer Ugeskrift for Laeger 167(45): 4261-4265
Nakayasu, Y.; Yoshimatsu, K.; Yokomizo, H.; Osawa, G.; Yano, Y.; Nakayama, M.; Sakuma, A.; Yamaguchi, K.; Shiozawa, S.; Shimakawa, T.; Katsube, T.; Naritaka, Y. 2013: Two cases of locally advanced colorectal cancer curatively resected after neoadjuvant chemotherapy with 5-fluorouracil, leucovorin, and oxaliplatin plus panitumumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 2029-2031
Meropol, N.J.; Creaven, P.J.; Petrelli, N.J. 1995: Metastatic colorectal cancer: advances in biochemical modulation and new drug development Seminars in Oncology 22(5): 509-524
Yang, J.-L.; Jackson, P.; Yu, Y.; Russell, P.J.; Markovic, B.; Crowe, P.J. 2002: Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer Anticancer Research 22(6a): 3337-3342
Watanabe, T.; Sawada, T.; Kubota, Y.; Ooya, M.; Masaki, T.; Sameshima, S.; Shinozaki, M.; Tsuno, N.; Uchiyama, M.; Sakaguchi, M. 1992: Continuous intra-arterial infusion chemotherapy in colorectal cancer patients with nonresectable metastatic liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1515-1518
Saltz, L.B. 2014: Management of metastatic colorectal cancer Oncology 28(10): 841
Bartlett, D.L.; Chu, E. 2012: Can metastatic colorectal cancer be cured? Oncology 26(3): 266-275
Tanada, M.; Nakata, M.; Kubo, Y.; Saeki, H.; Aogi, K.; Ishizaki, M.; Kurita, A.; Takashima, S. 2002: Pulmonary resection for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(12): 2135-2137
Patanaphan, V.; Salazar, O.M. 1993: Colorectal cancer: metastatic patterns and prognosis Southern Medical Journal 86(1): 38-41
Turja, J.; Grothey, A. 2008: Individualizing therapy for metastatic colorectal cancer Oncology 22(13): 1479-1481
Katsumoto, Y.; Aritake, N.; Endoh, A. 2010: The efficacy of cetuximab for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2523-2525
Govindarajan, R. 2000: Irinotecan and thalidomide in metastatic colorectal cancer Oncology 14(12 Suppl. 13): 29-32
Grenon, N.N. 2011: The evolving care of metastatic colorectal cancer Oncology 25(7 Suppl Nurse Ed): 44-45
Marshall, J.L. 2014: Maintenance therapy in metastatic colorectal cancer Clinical Advances in Hematology and Oncology: H&o 12(6): 388-390
Pfeiffer, P.; Qvortrup, C.; Hansen, T.P. 2009: Tailored treatment to patients with metastatic colorectal cancer Ugeskrift for Laeger 171(13): 1098
Muro, K. 2013: Team medicine in chemotherapy for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(4): 435-439
Lee, J.J.; Sun, W. 2016: Options for Second-Line Treatment in Metastatic Colorectal Cancer Clinical Advances in Hematology and Oncology: H&o 14(1): 46-54
Kamnerdsupaphon, P.; Lorvidhaya, V.; Chitapanarux, I.; Tonusin, A.; Sukthomya, V. 2007: FOLFIRI chemotherapy for metastatic colorectal cancer patients Journal of the Medical Association of Thailand 90(10): 2121-2127
Fermor, B.; Umpleby, H.C.; Lever, J.V.; Symes, M.O.; Williamson, R.C. 1986: Proliferative and metastatic potential of exfoliated colorectal cancer cells Journal of the National Cancer Institute 76(2): 347-349